Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Ticker SymbolTNDM
Company nameTandem Diabetes Care Inc
IPO dateNov 13, 2013
Founded at2008
CEOMr. John F. Sheridan
Number of employees2650
Security typeOrdinary Share
Fiscal year-endNov 13
Address12400 High Bluff Drive
CitySAN DIEGO
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code92130
Phone18583666900
Websitehttps://www.tandemdiabetes.com/
Ticker SymbolTNDM
IPO dateNov 13, 2013
Founded at2008
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data